Related Experiment Video
Updated: Jan 24, 2026

Digital Spatial Profiling for Characterization of the Microenvironment in Adult-Type Diffusely Infiltrating Glioma
Published on: September 13, 2022
Characterization of transcriptome profile and clinical features of a novel immunotherapy target CD204 in diffuse
Yongliang Yuan1,2, Qitai Zhao3,4, Songfeng Zhao1,2
1Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
CD204 is a specific marker of tumor-associated macrophages (TAMs) in glioma. However, the expression levels of CD204 and its involvement in glioma are not fully understood. In this large-scale study, we assessed the expression and function of CD204 in whole-grade glioma molecularly and clinically. In total, 1323 glioma samples, including 301 microarray data and 325 RNA-seq data from the Chinese Glioma Genome Atlas (CGGA) dataset and 697 RNA-seq data from The Cancer Genome Atlas (TCGA) dataset, were utilized. The statistical analysis and graphical work were mainly performed using the R software. Univariate and multivariate Cox analysis demonstrated that CD204 was an independent prognosticator in glioma patients. CD204 expression was positively correlated with the grade of malignancy. CD204 was consistently upregulated in wild-type isocitrate dehydrogenase glioma and highly expressed in mesenchymal glioblastoma. Gene ontology of CD204-related genes showed that CD204 was most enriched in inflammatory response and immune response. It was associated with the stromal and immune populations, especially the monocytic lineage, fibroblasts, and T cells. Circos plots revealed that CD204 was closely associated with many immune checkpoint regulators, especially TIM-3. CD204 expression is consistent with the malignant phenotype of glioma and independently predicts poor outcomes in glioma patients. Additionally, CD204+ TAMs, collaborating with other checkpoint members, may contribute to the dysfunction of T cells. These findings suggest that CD204 may be a promising target for glioma immunotherapy.
Insights
CD204, a marker for tumor-associated macrophages in glioma, independently predicts poor patient outcomes and correlates with malignancy. Targeting CD204 may offer a promising avenue for glioma immunotherapy.
Area of Science:
- Neuro-oncology
- Immunology
- Cancer Biomarkers
Background:
- CD204 is a marker for tumor-associated macrophages (TAMs) in glioma.
- Its expression and role in glioma progression remain incompletely understood.
Purpose of the Study:
- To investigate the expression, function, and prognostic significance of CD204 in glioma.
- To explore CD204's association with molecular subtypes and immune microenvironment.
Main Methods:
- Analysis of 1323 glioma samples from CGGA and TCGA datasets using microarray and RNA-seq data.
- Univariate and multivariate Cox regression analyses.
- Gene Ontology enrichment analysis and correlation studies with immune cell populations and checkpoint regulators.
Main Results:
- CD204 is an independent prognosticator of poor outcomes in glioma patients.
- CD204 expression correlates positively with glioma grade and is upregulated in mesenchymal glioblastoma.
- CD204 is enriched in inflammatory and immune responses, associated with monocytic lineage, fibroblasts, T cells, and immune checkpoint regulators like TIM-3.
Conclusions:
- CD204 expression reflects glioma malignancy and predicts poor prognosis.
- CD204+ TAMs may contribute to T-cell dysfunction via immune checkpoints.
- CD204 presents a potential therapeutic target for enhancing glioma immunotherapy.
Related Concept Videos
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Esophageal Strictures-II: Clinical Features and Management
Healthcare providers should gather a comprehensive medical history and conduct a physical examination for diagnosis. If esophageal stricture is...
Endocarditis II: Clinical Features of Infective Endocarditis
Pericarditis II: Clinical Features and Diagnostic Tests
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Myocarditis II: Clinical Features and Diagnostic Tests

